Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Asep Medical Holdings Inc C.ASEP

Alternate Symbol(s):  SEPSF

ASEP Medical Holdings Inc. is a Canada-based company, which is in the business of acquiring research and development assets, technologies and/or businesses in the area of life sciences and medical diagnostics. The Company’s consolidates three development-stage companies, including Sepset Biosciences Inc., ABT Innovations Inc., and SafeCoat Medical Inc. It provides medical devices with an anti-microbial, antifouling coating through its SafeCoat Medical Inc. The Company also provides diagnostic kits for predicting the onset of severe Sepsis and organ failure through its Sepset Biosciences Inc. The Company also offers peptide technology through its ABT Innovations Inc. Its technology includes diagnostic and therapeutic. It has developed a novel diagnostic assay for the early and rapid diagnosis of sepsis, based on the detection of molecular signatures of sepsis specific to the immune response, rather than the presence of a pathogen.


CSE:ASEP - Post by User

Asep Medical Holdings Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(144)
•••
Post by culturedpiggy01on Jun 15, 2022 6:59pm
81 Views
Post# 34759815

$ASEP.c obtains allowance of patent for SepsetER

$ASEP.c obtains allowance of patent for SepsetER

$ASEP. c just announced they’ve received an official allowance of patent for their 1st gen sepsis diagnostic tech - SepsetER. The SepsetER test is a blood-based gene expression assay which enable the diagnosis of severe sepsis within 1-2 hours which can be life-saving! more here https://ca.finance.yahoo.com/news/asep-medical-inc-announces-allowance-150900702.html

td, $ASEP.c @ $0.30 MC $16.84 M

 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities